#32026D0619Avrupa Komisyonu'nun 19 Mart 2026 tarihli 2026/619 sayılı Uygulama Kararı, bakır (II) oksit'in, Avrupa Parlamentosu ve Konseyi'nin 528/2012 sayılı Yönetmeliği uyarınca, ürün tipi 8'de biyosidal ürünlerde kullanımının onay süresinin sona erme tarihini ertelemektedir.
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The European Commission has extended the approval of copper (II) oxide for use in certain biocidal products until July 31, 2029. This decision affects manufacturers and users of biocidal products that contain copper (II) oxide, allowing them to continue using this substance while further evaluations are conducted.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- The expiry date of copper (II) oxide's approval has been postponed from July 31, 2026, to July 31, 2029.
- The decision allows for more time to evaluate the renewal application for copper (II) oxide.
- Manufacturers can continue using copper (II) oxide in biocidal products without interruption.
Obligations
What this law requires
Manufacturers and distributors of biocidal products containing copper (II) oxide for product-type 8 must ensure continued compliance with conditions set out in Annex I to Directive 98/8/EC until the approval expiry date of 31 July 2029
The evaluating competent authority of France must submit a renewal assessment report to the European Chemicals Agency by the first quarter of 2028
The European Chemicals Agency must prepare and submit an opinion on renewal of copper (II) oxide approval to the Commission within 270 days of receiving the renewal assessment report from the evaluating competent authority
The European Commission must make a final decision on whether to renew the approval of copper (II) oxide for product-type 8 biocidal products on the basis of the Agency's opinion and evaluating authority's assessment
Applicants for renewal of copper (II) oxide approval must provide sufficient data requested by the evaluating competent authority to enable full evaluation in accordance with Article 8(2) of Regulation (EU) No 528/2012